Dr. Mark Christopher Razzante
D.P.M. | Podiatrist - Foot & Ankle Surgery | 13+ years Exp
6688 Ridge Rd Ste 1110, Parma
Ohio, 44129-5706
440-885-1000 Maps & DirectionsDr. Mark Christopher Razzante is a Parma, Ohio based podiatrist with 13 years of experience in Podiatric Foot & Ankle Surgery. He completed his graduation from California School Of Podiatric Medicine in 2012. He is also affiliated with hospitals like Parma Community General Hospital. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Active license number of Dr. Mark Christopher Razzante for Podiatric Foot & Ankle Surgery is 59 in Ohio.
Dr. Mark Christopher Razzante provide comprehensive medical and surgical care for a wide spectrum of foot and ankle conditions, including common to complex disorders and injuries that affect people of all ages. He is uniquely qualified to detect the early stages of diseases that exhibit warning signs in the lower extremities, such as diabetes, arthritis and cardiovascular disease, and can manage foot conditions that may pose an ongoing threat to a patient’s overall health.
Complete Profile:
Dr. Mark Christopher Razzante speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
| Specialization: | Podiatric Foot & Ankle Surgery |
| Credentials: | D.P.M. |
| Experience: | 13+ years |
| Medical School Attended: | California School Of Podiatric Medicine |
| Graduation Year: | 2012 |
| Gender: | Male |
| Accepts Medicare Assignment: | May Accept |
| Practice Address: | 6688 Ridge Rd Ste 1110, Parma,
Ohio, 44129-5706 |
| Phone: | 440-885-1000 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
| PAC ID: | 7315248283 |
| Enrollment ID: | I20170908001999 |
| NPI Number: | 1295090470 |
| NPI Enumeration Date: | 12 Jul, 2012 |
| NPI Last Update On: | 21 Jul, 2022 |
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark Christopher Razzante are as mentioned below.
| License Number | Specialization | State | Status | |
| 59 | Podiatric Foot & Ankle Surgery | Ohio | Primary | |
Hospital Affiliation:
Doctors are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
| Hospital Name (CCN) | State | Hospital Type |
| Parma Community General Hospital (360041) | Parma, OH | Acute Care Hospital |
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Mark Christopher Razzante is associated with along with the number of members in that group.
| Organization Name (Group PAC ID) | Members |
| Cleveland Lower Extremity Specialists Llc (3274894621) | 4 |
| Ksu Foot And Ankle Clinic (1254588684) | 12 |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 6688 Ridge Rd Ste 1110,
Parma, Ohio |
| Zip: | 44129-5706 |
| Phone Number: | 440-885-1000 |
| Fax Number: | -- |
Patients can reach Dr. Mark Christopher Razzante at
6688 Ridge Rd Ste 1110, Parma, Ohio or can
call to book an appointment on 440-885-1000.
Comments/ Reviews:
Patients can read all the reviews posted for Dr. Mark Christopher Razzante below. You may also share your own experience like the quality of treatment, behavior, and overall care provided by Dr. Mark Christopher Razzante. It will help others make informed decisions.
** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.